Comment on CMS-2026-2047-0002
American Association for the Study of Liver DiseasesOpposeTrade association
Summary: The American Association for the Study of Liver Diseases (AASLD) opposes the interim final rule because it sets an unnecessarily narrow standard for the medical frailty exemption for Medicaid beneficiaries with serious medical conditions. They argue that requiring patients to demonstrate an inability to satisfy community engagement requirements—rather than just having a qualifying diagnosis—creates administrative burdens and risks interrupting essential care for those with chronic liver disease.
AASLD is pleased to submit the attached comments.